Rudolf A. de Boer

6 ta ish

University Medical Center Groningen

1. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

   John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi +35

   Maqola20196 iqtibos

   ABIABI:AkademIndex/2026.other.282514

2. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

   Theresa A. McDonagh, Marco Metra, Marianna Adamo +94

   Maqola20214 iqtibos

   ABIABI:AkademIndex/2026.other.456572

3. Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy

   Johann Bauersachs, Tobias König, Peter van der Meer +19

   MaqolaOAOchiq kirish20193 iqtibos

   ABIABI:AkademIndex/2026.other.115016

4. Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations

   Christian Mueller, Kenneth McDonald, Rudolf A. de Boer +15

   Sharh maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.295863

5. Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update

   Navin Suthahar, Wouter C. Meijers, Herman H.W. Silljé +3

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.405263

6. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

   Sheryl L. Chow, Alan S. Maisel, Inder S. Anand +11

   Sharh maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.474563